Deal watch: Immuno-oncology double-header at Bristol with Rigel, Flexus deals (Pink Sheet - Informa) - Mar 2, 2015 - “Its (Heptares) M1 agonist for cognitive disorder associated with Alzheimer’s is furthest advanced in development, with Phase Ib results due this summer.”
Anticipated P1 data • Alzheimer's Disease
|
|
A subscription to The Pink Sheet is required to access this article
|